304 related articles for article (PubMed ID: 36894112)
21. Maternal serum perfluoroalkyl substance mixtures and thyroid hormone concentrations in maternal and cord sera: The HOME Study.
Lebeaux RM; Doherty BT; Gallagher LG; Zoeller RT; Hoofnagle AN; Calafat AM; Karagas MR; Yolton K; Chen A; Lanphear BP; Braun JM; Romano ME
Environ Res; 2020 Jun; 185():109395. PubMed ID: 32222633
[TBL] [Abstract][Full Text] [Related]
22. Associations between exposure to a mixture of perfluoroalkyl and polyfluoroalkyl substances and age at menarche in adolescent girls utilizing three statistical models.
Guo M; Yu Y; Liu H; Zhu C
Chemosphere; 2023 Sep; 335():139054. PubMed ID: 37247673
[TBL] [Abstract][Full Text] [Related]
23. Higher free thyroxine associated with PFAS exposure in first trimester. The Odense Child Cohort.
Jensen RC; Glintborg D; Timmermann CAG; Nielsen F; Boye H; Madsen JB; Bilenberg N; Grandjean P; Jensen TK; Andersen MS
Environ Res; 2022 Sep; 212(Pt D):113492. PubMed ID: 35597289
[TBL] [Abstract][Full Text] [Related]
24. Prenatal exposures to per- and polyfluoroalkyl substances and epigenetic aging in umbilical cord blood: The Healthy Start study.
Niemiec SS; Kechris K; Pattee J; Yang IV; Adgate JL; Calafat AM; Dabelea D; Starling AP
Environ Res; 2023 Aug; 231(Pt 2):116215. PubMed ID: 37224946
[TBL] [Abstract][Full Text] [Related]
25. Association between maternal per- and polyfluoroalkyl substance exposure and newborn telomere length: Effect modification by birth seasons.
Pan D; Shao Y; Song Y; Huang D; Liu S; Zeng X; Liang J; Juan Jennifer Tan H; Qiu X
Environ Int; 2022 Mar; 161():107125. PubMed ID: 35183942
[TBL] [Abstract][Full Text] [Related]
26. Prenatal exposure to perfluoroalkyl substances and cord plasma lipid concentrations.
Tian Y; Miao M; Ji H; Zhang X; Chen A; Wang Z; Yuan W; Liang H
Environ Pollut; 2021 Jan; 268(Pt A):115426. PubMed ID: 33152632
[TBL] [Abstract][Full Text] [Related]
27. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
[TBL] [Abstract][Full Text] [Related]
28. Prenatal Exposure to Perfluoroalkyl Substances and Child Behavior at Age 12: A PELAGIE Mother-Child Cohort Study.
Tillaut H; Monfort C; Rouget F; Pelé F; Lainé F; Gaudreau E; Cordier S; Warembourg C; Saint-Amour D; Chevrier C
Environ Health Perspect; 2023 Nov; 131(11):117009. PubMed ID: 37971539
[TBL] [Abstract][Full Text] [Related]
29. Prenatal exposure to perfluoroalkyl substances and behavioral difficulties in childhood at 7 and 11 years.
Luo J; Xiao J; Gao Y; Ramlau-Hansen CH; Toft G; Li J; Obel C; Andersen SL; Deziel NC; Tseng WL; Inoue K; Bonefeld-Jørgensen EC; Olsen J; Liew Z
Environ Res; 2020 Dec; 191():110111. PubMed ID: 32846178
[TBL] [Abstract][Full Text] [Related]
30. A co-twin control study of in utero exposure to poly- and perfluoroalkyl substances and associations with neonatal thyroid-stimulating hormone.
Hu L; Mei H; Cai X; Xiang F; Li N; Huang Z; Duan Z; Yang P; Xiao H
Environ Res; 2023 Dec; 239(Pt 1):117350. PubMed ID: 37821063
[TBL] [Abstract][Full Text] [Related]
31. Epidemic-specific association of maternal exposure to per- and polyfluoroalkyl substances (PFAS) and their components with maternal glucose metabolism: A cross-sectional analysis in a birth cohort from Hong Kong.
Yang A; Tam CHT; Wong KK; Ozaki R; Lowe WL; Metzger BE; Chow E; Tam WH; Wong CKC; Ma RCW
Sci Total Environ; 2024 Mar; 917():170220. PubMed ID: 38278268
[TBL] [Abstract][Full Text] [Related]
32. Early-life exposure to perfluoroalkyl substances in relation to serum adipokines in a longitudinal birth cohort.
Shih YH; Blomberg AJ; Jørgensen LH; Weihe P; Grandjean P
Environ Res; 2022 Mar; 204(Pt A):111905. PubMed ID: 34419464
[TBL] [Abstract][Full Text] [Related]
33. Associations of paternal and maternal per- and polyfluoroalkyl substances exposure with cord serum reproductive hormones, placental steroidogenic enzyme and birth weight.
Yao Q; Gao Y; Zhang Y; Qin K; Liew Z; Tian Y
Chemosphere; 2021 Dec; 285():131521. PubMed ID: 34273704
[TBL] [Abstract][Full Text] [Related]
34. Prenatal exposure to perfluorooctane sulfonate alternatives and associations with neonatal thyroid stimulating hormone concentration: A birth cohort study.
Cao Z; Li J; Yang M; Gong H; Xiang F; Zheng H; Cai X; Xu S; Zhou A; Xiao H
Chemosphere; 2023 Jan; 311(Pt 1):136940. PubMed ID: 36273603
[TBL] [Abstract][Full Text] [Related]
35. Association between maternal exposure to per- and polyfluoroalkyl substances and serum markers of liver function during pregnancy in China: A mixture-based approach.
Liao Q; Tang P; Fan H; Song Y; Liang J; Huang H; Pan D; Mo M; LeiLei ; Lin M; Chen J; Wei H; Long J; Shao Y; Zeng X; Liu S; Huang D; Qiu X
Environ Pollut; 2023 Apr; 323():121348. PubMed ID: 36842621
[TBL] [Abstract][Full Text] [Related]
36. Environmental exposure to perfluoroalkyl substances in early pregnancy, maternal glucose homeostasis and the risk of gestational diabetes: A prospective cohort study.
Yu G; Jin M; Huang Y; Aimuzi R; Zheng T; Nian M; Tian Y; Wang W; Luo Z; Shen L; Wang X; Du Q; Xu W; Zhang J;
Environ Int; 2021 Nov; 156():106621. PubMed ID: 33984575
[TBL] [Abstract][Full Text] [Related]
37. How to investigate human health effects related to exposure to mixtures of per- and polyfluoroalkyl substances: A systematic review of statistical methods.
Rosato I; Zare Jeddi M; Ledda C; Gallo E; Fletcher T; Pitter G; Batzella E; Canova C
Environ Res; 2022 Apr; 205():112565. PubMed ID: 34915031
[TBL] [Abstract][Full Text] [Related]
38. Exposure to per- and polyfluoroalkyl substances in early pregnancy, risk of gestational diabetes mellitus, potential pathways, and influencing factors in pregnant women: A nested case-control study.
Zang L; Liu X; Xie X; Zhou X; Pan Y; Dai J
Environ Pollut; 2023 Jun; 326():121504. PubMed ID: 36965679
[TBL] [Abstract][Full Text] [Related]
39. Adverse birth outcomes related to concentrations of per- and polyfluoroalkyl substances (PFAS) in maternal blood collected from pregnant women in 1960-1966.
Zheng T; Kelsey K; Zhu C; Pennell KD; Yao Q; Manz KE; Zheng YF; Braun JM; Liu Y; Papandonatos G; Liu Q; Shi K; Brochman S; Buka SL
Environ Res; 2024 Jan; 241():117010. PubMed ID: 37696323
[TBL] [Abstract][Full Text] [Related]
40. Exposure to perfluoroalkyl substances (PFAS) and association with thyroid hormones in adolescent males.
Freire C; Vela-Soria F; Castiello F; Salamanca-Fernández E; Quesada-Jiménez R; López-Alados MC; Fernandez MF; Olea N
Int J Hyg Environ Health; 2023 Jul; 252():114219. PubMed ID: 37451108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
